Eveline Boucher

发表

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

Masatoshi Kudo, Yoon-Koo Kang, Won Young Tak, 2012 .

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

Mohamed Bouattour, Xun Lin, Yoon-Koo Kang, 2011, Clinical Cancer Research.

Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

Marc Peeters, Yasuhiro Shimada, Ben Tran, 2015, The New England journal of medicine.

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen)

P. Brissot, K. Boudjema, J. Raoul, 2002, Cancer Chemotherapy and Pharmacology.